FY 2026Q2 has been approved by the BOD
Summary by AI BETAClose X
Subject: The Company's consolidated financial report for FY 2026Q2 has been approved by the Board of Directors.
Contents:
1.Date of submission to the board of directors or approval by the board of directors:2026/08/12
2.Date of approval by the audit committee:2026/08/12
3.Start and end dates of financial reports or annual self-assessed financial information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):2026/1/1~2026/6/30
4.Operating revenue accumulated from 1/1 to end of the period (thousand NTD):4,645,427,824
5.Gross profit (loss) from operations accumulated from 1/1 to end of the period (thousand NTD):285,513,881
6.Net operating income (loss) accumulated from 1/1 to end of the period (thousand NTD):170,451,721
7.Profit (loss) before tax accumulated from 1/1 to end of the period (thousand NTD):168,897,620
8.Profit (loss) accumulated from 1/1 to end of the period (thousand NTD):127,012,192
9.Profit (loss) during the period attributable to owners of parent accumulated from 1/1 to end of the period (thousand NTD):109,893,220
10.Basic earnings (loss) per share accumulated from 1/1 to end of the period (NTD):7.84
11.Total assets end of the period (thousand NTD):5,622,576,474
12.Total liabilities end of the period (thousand NTD):3,502,988,890
13.Equity attributable to owners of parent end of the period (thousand NTD):1,907,936,607
14.Any other matters that need to be specified: None
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 34 minutes ago Avon Technologies plc
- 1 hour ago TBC Bank Group
- 1 hour ago Moneysupermarket.com Group
- 1 hour ago Dr. Martens
- 2 hours ago Neuberger Private Equity Partners Limited